Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Anti-Infectivity against Herpes Simplex Virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from Eucalyptus globulus Labill

V. Brezáni, V. Leláková, STS. Hassan, K. Berchová-Bímová, P. Nový, P. Klouček, P. Maršík, S. Dall'Acqua, J. Hošek, K. Šmejkal,

. 2018 ; 10 (7) : . [pub] 20180706

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19000576

Herpes simplex virus (HSV) causes numerous mild-to-serious human diseases, including mucocutaneous herpes infections and life-threatening herpes encephalitis. Moreover, herpes viral lesions can be complicated by inflammation and secondary bacterial infections. The development of resistance to antiviral drugs along with the undesirable side effects of these drugs are relevant argue for the development of new anti-HSV drugs with diverse mechanisms of action. Eucalyptus extracts have been used for decades to combat various infectious diseases. We isolated and studied 12 pure compounds and one mixture of two constitutional isomers from the leaves and twigs of E. globulus. The structures were identified by spectroscopic methods (NMR, HR-MS, IR) and all of them were tested for antiherpetic activity against the replication of antigen types HSV-1 and HSV-2. Tereticornate A (12) (IC50: 0.96 μg/mL; selectivity index CC50/IC50: 218.8) showed the strongest activity in the anti-HSV-1 assay, even greater than acyclovir (IC50: 1.92 μg/mL; selectivity index CC50/IC50: 109.4), a standard antiviral drug. Cypellocarpin C (5) (EC50: 0.73 μg/mL; selectivity index CC50/EC50: 287.7) showed the most potent anti-HSV-2 activity, also more intensive than acyclovir (EC50: 1.75 μg/mL; selectivity index CC50/EC50: 120.0). The antimicrobial activity of the isolated compounds was also evaluated against the bacteria Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Pseudomonas aeruginosa and the yeast Candida albicans. The anti-inflammatory potential was examined using LPS-stimulated THP-1-XBlue™-MD2-CD14 and THP-1 macrophages and focusing on the influences of the NF-κB/AP-1 activity and the secretion of pro-inflammatory cytokines IL-1β and TNF-α.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000576
003      
CZ-PrNML
005      
20190110113556.0
007      
ta
008      
190107s2018 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/v10070360 $2 doi
035    __
$a (PubMed)29986399
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Brezáni, Viliam $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého třída 1946/1, 612 42 Brno, Czech Republic. brezani.viliam@gmail.com.
245    10
$a Anti-Infectivity against Herpes Simplex Virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from Eucalyptus globulus Labill / $c V. Brezáni, V. Leláková, STS. Hassan, K. Berchová-Bímová, P. Nový, P. Klouček, P. Maršík, S. Dall'Acqua, J. Hošek, K. Šmejkal,
520    9_
$a Herpes simplex virus (HSV) causes numerous mild-to-serious human diseases, including mucocutaneous herpes infections and life-threatening herpes encephalitis. Moreover, herpes viral lesions can be complicated by inflammation and secondary bacterial infections. The development of resistance to antiviral drugs along with the undesirable side effects of these drugs are relevant argue for the development of new anti-HSV drugs with diverse mechanisms of action. Eucalyptus extracts have been used for decades to combat various infectious diseases. We isolated and studied 12 pure compounds and one mixture of two constitutional isomers from the leaves and twigs of E. globulus. The structures were identified by spectroscopic methods (NMR, HR-MS, IR) and all of them were tested for antiherpetic activity against the replication of antigen types HSV-1 and HSV-2. Tereticornate A (12) (IC50: 0.96 μg/mL; selectivity index CC50/IC50: 218.8) showed the strongest activity in the anti-HSV-1 assay, even greater than acyclovir (IC50: 1.92 μg/mL; selectivity index CC50/IC50: 109.4), a standard antiviral drug. Cypellocarpin C (5) (EC50: 0.73 μg/mL; selectivity index CC50/EC50: 287.7) showed the most potent anti-HSV-2 activity, also more intensive than acyclovir (EC50: 1.75 μg/mL; selectivity index CC50/EC50: 120.0). The antimicrobial activity of the isolated compounds was also evaluated against the bacteria Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Pseudomonas aeruginosa and the yeast Candida albicans. The anti-inflammatory potential was examined using LPS-stimulated THP-1-XBlue™-MD2-CD14 and THP-1 macrophages and focusing on the influences of the NF-κB/AP-1 activity and the secretion of pro-inflammatory cytokines IL-1β and TNF-α.
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $x chemie $x farmakologie $7 D000900
650    _2
$a antiinfekční látky $x chemie $x farmakologie $7 D000890
650    _2
$a antiflogistika $x chemie $x farmakologie $7 D000893
650    _2
$a antioxidancia $x metabolismus $7 D000975
650    _2
$a antivirové látky $x chemie $x farmakologie $7 D000998
650    _2
$a buněčné linie $7 D002460
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a Cercopithecus aethiops $7 D002522
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a Eucalyptus $x chemie $7 D005052
650    _2
$a herpes simplex $x metabolismus $x virologie $7 D006561
650    _2
$a lidé $7 D006801
650    _2
$a NF-kappa B $x metabolismus $7 D016328
650    _2
$a rostlinné extrakty $x chemie $x farmakologie $7 D010936
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a Simplexvirus $x účinky léků $x fyziologie $7 D018139
650    _2
$a transkripční faktor AP-1 $x metabolismus $7 D018808
650    _2
$a Vero buňky $7 D014709
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Leláková, Veronika $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého třída 1946/1, 612 42 Brno, Czech Republic. veronika.lelakova@gmail.com.
700    1_
$a Hassan, Sherif T S $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého třída 1946/1, 612 42 Brno, Czech Republic. sherif.hassan@seznam.cz.
700    1_
$a Berchová-Bímová, Kateřina $u Department of Applied Ecology, Faculty of Environmental Sciences, Czech University of Life Sciences Prague, Kamýcká 129, 165 21 Praha 6-Suchdol, Czech Republic. berchova@knc.czu.cz.
700    1_
$a Nový, Pavel $u Department of Quality of Agricultural Products, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamýcká 129, 165 21 Praha 6-Suchdol, Czech Republic. novy@af.czu.cz.
700    1_
$a Klouček, Pavel $u Department of Quality of Agricultural Products, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamýcká 129, 165 21 Praha 6-Suchdol, Czech Republic. kloucek@af.czu.cz.
700    1_
$a Maršík, Petr $u Department of Quality of Agricultural Products, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamýcká 129, 165 21 Praha 6-Suchdol, Czech Republic. marsik@af.czu.cz.
700    1_
$a Dall'Acqua, Stefano $u Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via F. Marzolo 5, 351 31 Padua, Italy. stefano.dallacqua@unipd.it.
700    1_
$a Hošek, Jan $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého třída 1946/1, 612 42 Brno, Czech Republic. hosekj@vfu.cz.
700    1_
$a Šmejkal, Karel $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého třída 1946/1, 612 42 Brno, Czech Republic. karel.mejkal@post.cz.
773    0_
$w MED00177099 $t Viruses $x 1999-4915 $g Roč. 10, č. 7 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29986399 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190110113759 $b ABA008
999    __
$a ok $b bmc $g 1364630 $s 1038699
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 10 $c 7 $e 20180706 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Archiving options